Fundz

Who to call at Sunflower Therapeutics, and when

Fundz watches for the moments Sunflower Therapeutics starts buying, and tells you who to reach.

  • An alert the day Sunflower Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sunflower Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sunflower Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Sunflower Therapeutics Closes $3M Agreement for Future Equity (SAFE) with Oversubscription

Dec 03, 2024

Contract Type

agreement

MedfordBiotechnology

Description

Sunflower Therapeutics announced today the oversubscription of a $3M Simple Agreement for Future Equity (SAFE), which underscores ongoing support for the company’s commercial goals. This oversubscription provides the necessary runway to support the continued launch of Sunflower’s innovative Daisy Petal™ and Dahlia Petal™ perfusion fermentation systems.

Company Information

Company

Sunflower Therapeutics

Location

200 Boston Ave

Medford, Massachusetts, United States

About

Sunflower Therapeutics is a unique biotech with a mission to transform bioeconomies worldwide by creating accessible solutions for protein product development and commercial manufacturing. Using our core technologies – an efficient host, data-driven methods for process development, and continuous biomanufacturing equipment – our team aims to democratize bioprocessing.

Related People

Kerry
Senior decision-maker at this company
••••••••@••••••••

See Kerry's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Sunflower Therapeutics's next move

Learn about Strategic plan

Sunflower Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.